Literature DB >> 6730857

Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid.

S Balabanov, U Töllner, H P Richter, F Pohlandt, G Gaedicke, W M Teller.   

Abstract

Parathyroid hormone (PTH) was measured radioimmunologically in simultaneous plasma and cerebrospinal fluid (CSF) samples obtained from 72 patients aged 20 to 80 years without endocrine or psychiatric diseases and from 2 patients aged 40 and 70 years with secondary hyperparathyroidism due to renal insufficiency. They underwent routine diagnostic lumbar puncture because of suspected prolapse of a disc. Total calcium (Ca) and magnesium (Mg) were also determined in these samples by complexometry . The following findings were obtained (ng/ml, median, range in brackets): Plasma PTH 1.7 (0.7-6.6); CSF PTH 0.8 (0.5-2.3), respectively. No correlation was found between PTH concentrations in plasma and CSF in all 74 samples. The Ca concentrations in plasma, with a median of 2.3 mmol/l (2.1-2.6) were significantly higher than the Ca concentrations in CSF (median 1.1 mmol/l, range 0.4-1.3). The correlation between PTH and calcium levels in CSF was only weak (r = 0.284 P less than 0.05). The Mg levels in CSF (median 1.1 mmol/l, range 0.7-1.6) were higher than Mg concentrations in plasma (median 0.9 mmol/l, range 0.6-1.1). No correlation was found between PTH and Mg in CSF. Our study demonstrated that in man PTH is a normal constituent of CSF.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6730857     DOI: 10.1530/acta.0.1060227

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

Review 1.  Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.

Authors:  Matthias Büttner; Thomas J Musholt; Susanne Singer
Journal:  Endocrine       Date:  2017-08-18       Impact factor: 3.633

2.  Distribution and concentration of immunoreactive parathyroid hormone in brain and pituitary of sheep.

Authors:  S Balabanova; O King; W M Teller; G Reinhardt
Journal:  Klin Wochenschr       Date:  1985-05-02

3.  Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.

Authors:  Gaia Tabacco; Yu-Kwang Donovan Tay; Natalie E Cusano; John Williams; Beatriz Omeragic; Rukhana Majeed; Maximo Gomez Almonte; Mishaela R Rubin; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 5.958

4.  Parathyroid hormone secretion by brain and pituitary of sheep.

Authors:  S Balabanova; J Peter; G Reinhardt
Journal:  Klin Wochenschr       Date:  1986-02-17

5.  The effect of PTH(1-84) on quality of life in hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Dinaz Irani; Amanda Tulley; James Sliney; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-04-17       Impact factor: 5.958

6.  PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy.

Authors:  Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Dinaz Irani; Laura Anderson; Elizabeth Levy; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2014-06-30       Impact factor: 5.958

Review 7.  A Review of the Relationship of the Cerebrospinal Fluid Changes During the Dysregulation of Parathyroid Hormone With Psychiatric or Neurological Manifestations.

Authors:  Ifrah Kaleem; Josh Alexander; Mohamed Hisbulla; Vishmita Kannichamy; Vinayak Mishra; Amit Banerjee; Arohi B Gandhi; Safeera Khan
Journal:  Cureus       Date:  2021-01-13

8.  A Pilot Study of Cognition Among Hypoparathyroid Adults.

Authors:  Mishaela R Rubin; Gaia Tabacco; Beatriz Omeragic; Rukshana Majeed; Christiane Hale; Adam M Brickman
Journal:  J Endocr Soc       Date:  2022-01-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.